Cancers, Vol. 12, Pages 1402: Gastric Cancer Staging: Is It Time for Magnetic Resonance Imaging?

Cancers, Vol. 12, Pages 1402: Gastric Cancer Staging: Is It Time for Magnetic Resonance Imaging? Cancers doi: 10.3390/cancers12061402 Authors: Matteo Renzulli Alfredo Clemente Daniele Spinelli Anna Maria Ierardi Giovanni Marasco Davide Farina Stefano Brocchi Matteo Ravaioli Irene Pettinari Matteo Cescon Alfonso Reginelli Salvatore Cappabianca Gianpaolo Carrafiello Rita Golfieri Gastric cancer (GC) is a common cancer worldwide. Its incidence and mortality vary depending on geographic area, with the highest rates in Asian countries, particularly in China, Japan, and South Korea. Accurate imaging staging has become crucial for the application of various treatment strategies, especially for curative treatments in early stages. Unfortunately, most GCs are still diagnosed at an advanced stage, with the peritoneum (61–80%), distant lymph nodes (44–50%), and liver (26–38%) as the most common metastatic locations. Metastatic disease is limited to the peritoneum in 58% of cases; in nonperitoneal distant metastases, the most involved GC metastasization site is the liver (82%). The eighth edition of the tumor-node-metastasis staging system is the most commonly used system for determining GC prognosis. Endoscopic ultrasonography, computed tomography, and 18-fluorideoxyglucose positron emission tomography are historically the most accurate imaging techniques for GC staging. However, studies have recently shown rene...
Source: Cancers - Category: Cancer & Oncology Authors: Tags: Review Source Type: research